Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06150560 · ClinicalTrials.gov registry record · Phase 3
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
A Phase 3 study of High Blood Pressure and Coarctation of Aorta, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06150560 is a Phase 3 study of High Blood Pressure and Coarctation of Aorta that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, below the 499-participant average among 23 other High Blood Pressure trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06150560, a Phase 3 study of High Blood Pressure and Coarctation of Aorta, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness and mechanism of action of Losartan in the treatment of coarctation of aorta.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Losartan
- DRUG Amlodipine
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2028-06-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06150560
The ClinicalTrials.gov registry entry for NCT06150560 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 499-participant average among 23 other High Blood Pressure trials with a reported enrollment target (76% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with High Blood Pressure appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06150560 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06150560 about?
NCT06150560 is a clinical study titled "A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)". The purpose of this study is to evaluate the effectiveness and mechanism of action of Losartan in the treatment of coarctation of aorta.
What is the current status of trial NCT06150560?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2024-04-01. Estimated completion is 2028-06-01.
What conditions does trial NCT06150560 study?
This clinical trial studies the following conditions: High Blood Pressure, Coarctation of Aorta.
What interventions are being tested in trial NCT06150560?
The interventions under investigation include: Placebo (DRUG), Losartan (DRUG), Amlodipine (DRUG).
Who is sponsoring clinical trial NCT06150560?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06150560 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for High Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
RECRUITING · Phase 3
-
Addressing Hypertension Care in Africa Program
RECRUITING · NA
-
Blood Pressure Care for Advancing Real-World Evidence (BPCARE)
RECRUITING · NA
-
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
RECRUITING · NA
-
Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
RECRUITING · NA
-
Polypill for Prevention of Cardiomyopathy
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.